There is also the most aggressive form—triple negative breast cancer (TNBC), characterized by the absence of ER, PR, and HER2 receptor expression, which makes cancer cells unresponsive to endocrine therapy or HER2-targeted treatments [10,19]. The gene discussed is ERBB2; the disease is cancer.